Regulatory
Key facts
FDA issued accelerated approval for Genglycos (pariglasgene brecaparvovec-opnr)
Key facts
The approval applies to adults and pediatric patients 8 years of age and older with GSDIa
Key facts
Genglycos is intended to reduce daily cornstarch intake as an adjunct to nutritional management
Atlas Watchline
The FDA granted accelerated approval to Genglycos for adults and children 8 and older with glycogen…